PHLDA2 Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

PHLDA2 Polyklonal Antikörper für IHC, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human und mehr (1)

Anwendung

WB, IHC, ELISA

Konjugation

Unkonjugiert

Publikationen

5

Kat-Nr. : 14661-1-AP

Synonyme

BRW1C, BWR1C, HLDA2, IPL, p17 BWR1C, PHLDA2, TSSC3

---

Galerie der Validierungsdaten

• 

  WB analysis of human placenta using 14661-1-AP

  human placenta tissue were subjected to SDS PAGE followed by western blot with 14661-1-AP (PHLDA2 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 14661-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 14661-1-AP (PHLDA2 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours.

• 

  WB analysis of MCF-7 using 14661-1-AP

  WB result of PHLDA2 antibody (14661-1-AP; 1:600; incubated at room temperature for 1.5 hours) with sh-Control and sh-PHLDA2 transfected MCF-7 cells.

• 

  WB analysis of PC-3 using 14661-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 14661-1-AP (PHLDA2 antibody) at dilution of 1:600 incubated at room temperature for 1.5 hours.

• 

  IHC staining of human prostate cancer using 14661-1-AP

  Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue slide using 14661-1-AP (PHLDA2 antibody) at dilution of 1:200 (under 10x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human prostate cancer using 14661-1-AP

  Immunohistochemical analysis of paraffin-embedded human prostate cancer tissue slide using 14661-1-AP (PHLDA2 antibody) at dilution of 1:200 (under 40x lens. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: L02-Zellen, humanes Plazenta-Gewebe, MCF-7-Zellen, PC-3-Zellen
• Erfolgreiche Detektion in IHC: humanes Prostatakarzinomgewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:1000
• Immunhistochemie (IHC): IHC : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 2 publications below
• WB: See 5 publications below
• IHC: See 2 publications below

Produktinformation

14661-1-AP bindet in WB, IHC, ELISA PHLDA2 und zeigt Reaktivität mit human

• Getestete Reaktivität: human
• In Publikationen genannte Reaktivität: human, Ziege
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: PHLDA2 fusion protein Ag6331
• Vollständiger Name: pleckstrin homology-like domain, family A, member 2
• Berechnetes Molekulargewicht: 17 kDa
• Beobachtetes Molekulargewicht: 20-25 kDa
• GenBank-Zugangsnummer: BC005034
• Gene symbol: PHLDA2
• Gene ID (NCBI): 7262
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Publikationen

Species	Application	Title
human	WB,IHC	Nat Commun; Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.; Authors - Yuji Kubota
human	WB	Aging (Albany NY); PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway.; Authors - Zhan Ma ; KD Validated
human	WB	Pathol Res Pract; FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells; Authors - Guangyi Liu ; KD Validated
Goat	WB	Gene; Inhibition of PHLDA2 transcription by DNA methylation and YY1 in goat placenta.; Authors - Ruihong Wang
human	IHC,WB	Sci Rep; Characteristics of lactate metabolism phenotype in hepatocellular carcinoma; Authors - Jiacheng Zhang